sec filing
TT
NASDAQ · TTRX
Turn Therapeutics Inc.
Healthcare · Biotechnology
$12.49
Down-$0.77 (-5.81%)
Updated Sep 27, 2026, 10:27 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 96.14M
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $2.57 – $26.50
- Volume
- 89.95K
- Avg. volume
- 595.4K
Price performance
TTRX price history
1M range · 19 trading sessions · Daily adjusted prices
TTRX closed at $12.49 after 19 trading sessions, up 30.10% for the selected period.
- Last close
- $12.49
- Period change
- +30.10%
- Period low
- $9.60
- Period high
- $15.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $13.24 | $13.68 | $12.30 | $12.49 | 89.95K |
| Sep 24, 2026 | $13.50 | $13.8799 | $12.065 | $13.26 | 244.96K |
| Sep 23, 2026 | $15.30 | $15.65 | $13.50 | $13.51 | 101.58K |
| Sep 22, 2026 | $15.31 | $15.435 | $14.53 | $15.29 | 122.65K |
| Sep 21, 2026 | $15.05 | $15.555 | $13.59 | $15.34 | 172.96K |
| Sep 18, 2026 | $13.80 | $16.45 | $13.80 | $14.94 | 929.98K |
| Sep 17, 2026 | $13.65 | $14.50 | $13.65 | $13.82 | 199.9K |
| Sep 16, 2026 | $13.46 | $14.21 | $13.40 | $13.72 | 150.4K |
| Sep 15, 2026 | $13.37 | $13.85 | $13.215 | $13.46 | 85.17K |
| Sep 14, 2026 | $12.43 | $13.82 | $12.11 | $13.45 | 131.46K |
| Sep 11, 2026 | $13.30 | $14.25 | $12.63 | $12.69 | 135.66K |
| Sep 10, 2026 | $13.34 | $14.2899 | $13.03 | $13.38 | 125.08K |
| Sep 9, 2026 | $12.61 | $14.39 | $12.58 | $13.75 | 277.54K |
| Sep 8, 2026 | $9.99 | $12.6786 | $9.82 | $12.66 | 321.76K |
| Sep 4, 2026 | $9.975 | $10.50 | $9.70 | $9.80 | 70.57K |
| Sep 3, 2026 | $9.67 | $10.4999 | $9.67 | $10.07 | 82.47K |
| Sep 2, 2026 | $9.70 | $10.25 | $9.00 | $9.67 | 106.48K |
| Sep 1, 2026 | $9.60 | $10.285 | $9.28 | $9.82 | 43.21K |
| Aug 31, 2026 | $9.83 | $10.25 | $9.50 | $9.60 | 31.64K |
Latest TTRX news
The latest Smart Investors Daily articles mentioning TTRX.
Stock researchMarket Activity · Insider Trades
Loading stock research…

